Formulary Search
Search Results : Asthma (Salbutamol (Salbulin Novolizer) - Asthma)
Show Icon and Status Keys
- Not Specified
- Inhaler (dry powder)
Easyhaler Salbutamol is preferred. Ventolin Accuhaler is a suitable low-carbon alternative DPI.
Not for initiation in new patients.
- Inhaler (Metered Dose)
Children only - ICS alone not recommended in adults with asthma.
First line ICS in children.
Prescribe by BRAND
- Inhaler (dry powder)
Not licensed in <18 years. ICS alone not recommended in adults with asthma.
Not to be initiated in new patients.
- Inhaler (breath actuated Metered Dose)
No dose counter, high carbon footprint.
Not for initiation in new patients.
- Inhaler (breath actuated Metered Dose)
No dose counter, high carbon footprint.
Not for initiation in new patients.
- Inhaler (Metered Dose)
Children only - ICS alone not recommended in adults with asthma.
Second line ICS in children (Clenil Modulite is 1st line).
No dose counter.
Prescribe by BRAND
- Inhaler (dry powder)
Fostair NEXThaler 100/6 - licensed from 18 years of age.
Not licensed for AIR.
Second line in adult asthma requiring MART. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)
- Inhaler (dry powder)
Fostair NEXThaler 200/6 - High dose ICS/LABA for specialist recommendation only.
Not licensed for COPD.
Prescribe by BRAND.
- Inhaler (Metered Dose)
Fostair 100/6, 200/6 not licensed in under 18 years. Not licensed for AIR.
Not for initiation in new patients. Proxor device is much less expensive.
Further information is being sought with regard to Proxor / Fostair bioequivalence. To be reviewed in Jul/Aug 2025.
- Inhaler (Metered Dose)
Proxor 100/6 (new device) - licensed for MART in adults - second line. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)
Not licensed in under 18 years.
Proxor is equivalent to Fostair and is the most cost-effective ICS/formoterol pMDI.
- Inhaler (Metered Dose)
Proxor 200/6 (new device) - higher dose ICS/LABA for specialist recommendation only.
Licensed for MART in adults - second line.
Not licensed in under 18 years. Not licensed for COPD
Proxor is equivalent to Fostair and is the most cost-effective ICS/formoterol pMDI.
- Inhaler (Metered Dose)
Trimbow 87/5/9 and 172/5/9 - specialist recommendation only
- Inhaler (dry powder)
Not for initiation in new patients.
- Inhaler (dry powder)
Children only - ICS alone not recommended in adults with asthma.
DPI licensed in children, cost effective.
Prescribe by BRAND.
Licensed in children.
- Inhaler (dry powder)
Children only - ICS alone not recommended in adults with asthma.
Licensed in children. Second line (Easyhaler budesonide device is preferred).
Prescribe by BRAND
- Nebules
Specialist recommendation following patient initiation and education on nebuliser therapy.
- Inhaler (dry powder)
DuoResp Spiromax 160/4.5 - licensed for AIR and MART from 12 years of age.
Second line. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)
Prescribe by BRAND.
- Inhaler (dry powder)
DuoResp Spiromax 320/9 - higher dose ICS/LABA for specialist recommendation only.
Prescribe by BRAND.
- Inhaler (dry powder)
Fobumix Easyhaler 80/4.5 and 160/4.5 - licensed in children.
Cost-effective choice for AIR and MART.
Prescribe by BRAND.
- Inhaler (dry powder)
Fobumix Easyhaler 320/9 - higher dose ICS/LABA for specialist recommendation only.
Prescribe by BRAND.
- Inhaler (dry powder)
Symbicort Turbohaler 100/6 and 200/6 - Licensed for AIR and MART.
More costly device so second line option. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)
Prescribe by BRAND.
- Inhaler (dry powder)
Symbicort Turbohaler 400/12 - higher dose ICS/LABA for specialist recommendation only.
Prescribe by BRAND
- Inhaler (dry powder)
Flixotide Accuhaler - specialist paediatric recommendation. 50 and 100mcg strength only.
Children only - ICS alone not recommended in adults with asthma.
Prescribe by BRAND
- Inhaler (Metered Dose)
Flixotide Evohaler - specialist paediatric recommendation. 50 and 125 mcg strength only.
Children only - ICS alone not recommended in adults with asthma.
Prescribe by BRAND
- Inhaler (Metered Dose)
Flutiform 50/5 - For children aged 5 to 11 years needing ICS/LABA, unable to use DPI.
Not recommended for use in adults.
Prescribe by BRAND
- Inhaler (Metered Dose)
Flutiform 125/5 and 250/10 - on request from specialist team only.
Very high carbon footprint.
Prescribe by BRAND.
- Inhaler (Metered Dose)
Salmeterol containing preparations not recommended in asthma guideline.
Increased risk of adrenal suppression in children.
Not for initiation in new patients.
- Inhaler (dry powder)
Salmeterol containing preparations not recommended in asthma guideline.
Increased risk of adrenal suppression in children.
Not for initiation in new patients.
- Inhaler (dry powder)
Salmeterol containing preparations not recommended in asthma guideline.
Increased risk of adrenal suppression in children.
Not for initiation in new patients
- Inhaler (Metered Dose)
Seretide Evohaler 50/25 - for children aged 5 to 11 years needing ICS/LABA, unable to use DPI.
Not recommended for use in adults.
Prescribe by BRAND.
- Inhaler (Metered Dose)
Salmeterol containing preparations not recommended in asthma guideline.
Increased risk of adrenal suppression in children.
Not for initiation in new patients.
- Inhaler (dry powder)
Relvar Ellipta 92/22 and 184/22 - higher dose ICS LABA for specialist recommendation only.
Once daily formulation.
Prescribe by BRAND.
- Inhaler (dry powder)
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
- Nebules
Specialist recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.
- Inhaler (dry powder)
Specialist recommendation only. Used in severe asthma.
Only triple therapy DPI licensed for asthma.
Prescribe by BRAND
- Inhaler (dry powder)
Cost-effective, low carbon DPI.
Prescribe by BRAND.
- Nebules
Specialist recommendation following patient initiation and education on nebuliser therapy, unless for administration as PSD in practice for acute attack.
- Inhaler (breath actuated Metered Dose)
Second line, as an alternative to Salbutamol Easyhaler, in patients needing a breath actuated inhaler
Second line - for patients needing a breath-actuated device
- Inhaler (Metered Dose)
No dose counter. Lower carbon footprint than Ventolin Evohaler.
Prescribe by BRAND.
- Inhaler (dry powder)
Easyhaler Salbutamol is preferred. Ventolin Accuhaler is a suitable low-carbon alternative DPI.
Prescribe by BRAND
- Inhaler (Metered Dose)
No dose counter. Higher carbon footprint than the Salamol MDI.
Not for initiation in new patients.
- Inhaler (Metered Dose)
Serevent Evohaler
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
- Inhaler (dry powder)
Serevent Accuhaler
LABA monotherapy no longer recommended for asthma or COPD.
Not for initiation in new patients.
- Inhaler (dry powder)
Alternative low carbon DPI (Easyhaler Salbutamol is the more cost-effective treatment option)
Prescribe by BRAND.
- Nebules
Specialist recommendation following patient initiation and education on nebuliser therapy
- Injection
- Soft mist inhaler
Only LAMA licensed in asthma.
Prescribe by BRAND.
- Chewable tablets
- Sachets (granules)
- Tablets
- Inhaler (Metered Dose)
Symbicort 100/3 - Useful in children and under 18yrs . Useful for patients needing a pMDI licensed for MART.
Prescribe by BRAND
- Not Specified
- Injection
- Modified release tablets
- Oral solution
- Tablets
- Inhaler (dry powder)
LABA monotherapy no longer recommended for asthma or COPD.
Not to be initiated in new patients.
Not for initiation in new patients.
- Modified release tablets